Company Filing History:
Years Active: 2020
Title: Ellen Sieber McMaster: Innovator in Non-Systemic TGR5 Agonists
Introduction
Ellen Sieber McMaster is a notable inventor based in Langhorne, PA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of non-systemic TGR5 agonists. Her work focuses on innovative compounds that have the potential to treat diabetic diseases in humans.
Latest Patents
Ellen holds a patent for her invention titled "Non-systemic TGR5 agonists." This patent describes tricyclic compounds of formula (I) and formula (II), or a pharmaceutically acceptable salt thereof. The compounds are recognized for their utility as non-systemic TGR5 agonists, which can be employed in the treatment of diabetic diseases. The invention also includes a pharmaceutical composition containing these tricyclic compounds and outlines methods for their production and application in treating patients with metabolic disorders. Additionally, these compounds may be used in conjunction with other anti-diabetic medications.
Career Highlights
Ellen is associated with Venenum Biodesign, LLC, where she continues to advance her research and development efforts. Her innovative approach and dedication to improving health outcomes through her inventions have established her as a prominent figure in her field.
Collaborations
Ellen has collaborated with notable colleagues, including Chia-Yu Huang and Brian F McGuinness. These partnerships have contributed to the success and impact of her research endeavors.
Conclusion
Ellen Sieber McMaster's work in developing non-systemic TGR5 agonists represents a significant advancement in the treatment of diabetic diseases. Her innovative contributions and collaborations highlight her commitment to improving healthcare through scientific research.